pe ratio 10, page-2

Jovann, isnt PNO in the N/A category? ie we are losing money?

Earnings is profit, not revenue. Until we reach breakeven it is 1step forward and two steps back. Each quarter more accumulative losses and more dilution. Slowly the share register is becoming JP and Celtic controlled.

But, I get your point that any sniff of a profit and a decent growth profile would see the sp run hard. Domestically unlikely to be profitable anytime soon. Maybe when the real version of RED is released. What it does for burns is impressive and more unique than Thermalife which needs to compete with Voltaren and others.

But one international deal would likely be instant profit. Even a $1mil profit at PE of 10 is a $10mil market cap. Then add in growth for product extensions.

Im not overly confident of a deal. Crossmark came and went. Then Medtrak. Perry will be next.

But I am slightly confident that we can shift to the OBJ model. Find big name partners to pay for R&D. We already have cost effective partnerships with universities. If we can gain the deep pockets and reputations of a P&G then sentiment will change.

Trim costs by having others pay our bills. Then that small amount of revenue that Thermalife generates might equate to a small profit. Currently we lose about $2mil per year. Our entire market cap. That is not sustainable...obviously.